Page 4 - Bio Techne News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Last week, you might have seen that Bio-Techne Corporation ( NASDAQ:TECH ) released its quarterly result to the market...

Dorsey & Whitney Trust CO LLC increased its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 1.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 155,984 shares of the biotechnology company’s stock after acquiring an additional 1,538 shares during the quarter. […]

Fox Run Management L.L.C. acquired a new position in Bio-Techne Co. (NASDAQ:TECH – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 5,898 shares of the biotechnology company’s stock, valued at approximately $401,000. Several other institutional investors and hedge funds have also […]

Bio-Techne (NASDAQ:TECH – Get Free Report) had its price objective dropped by equities researchers at Stephens from $92.00 to $87.00 in a research note issued on Friday, Benzinga reports. The firm presently has an “overweight” rating on the biotechnology company’s stock. Stephens’ target price would indicate a potential upside of 31.72% from the stock’s current […]

Bio-Techne Corporation (NASDAQ:TECH) Q2 2024 Earnings Call Transcript February 1, 2024 Bio-Techne Corporation misses on earnings expectations. Reported EPS is $0.4 EPS, expectations were $0.42. Bio-Techne Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to the Bio-Techne […]